Forum Financial Management LP Purchases 123 Shares of Intuitive Surgical, Inc. $ISRG

Forum Financial Management LP grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,129 shares of the medical equipment provider’s stock after acquiring an additional 123 shares during the quarter. Forum Financial Management LP’s holdings in Intuitive Surgical were worth $1,157,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently modified their holdings of ISRG. Brighton Jones LLC boosted its position in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after buying an additional 731 shares during the last quarter. GAMMA Investing LLC boosted its position in shares of Intuitive Surgical by 9.3% during the first quarter. GAMMA Investing LLC now owns 6,115 shares of the medical equipment provider’s stock valued at $3,029,000 after buying an additional 518 shares during the last quarter. Consolidated Portfolio Review Corp purchased a new position in shares of Intuitive Surgical during the first quarter valued at approximately $208,000. Golden State Equity Partners boosted its position in shares of Intuitive Surgical by 14.6% during the first quarter. Golden State Equity Partners now owns 1,209 shares of the medical equipment provider’s stock valued at $599,000 after buying an additional 154 shares during the last quarter. Finally, Alpine Bank Wealth Management purchased a new position in shares of Intuitive Surgical during the first quarter valued at approximately $65,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $551.30 on Friday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The business’s fifty day moving average price is $456.77 and its 200-day moving average price is $496.40. The stock has a market capitalization of $197.63 billion, a PE ratio of 72.92, a P/E/G ratio of 5.53 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the prior year, the firm earned $1.84 EPS. The business’s revenue for the quarter was up 22.9% compared to the same quarter last year. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Amy L. Ladd sold 336 shares of the company’s stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director owned 1,074 shares of the company’s stock, valued at $504,898.14. This represents a 23.83% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. This represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 40,724 shares of company stock worth $19,500,332 in the last ninety days. Insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ISRG. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Wednesday, October 8th. Jefferies Financial Group boosted their price objective on Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research report on Wednesday. Evercore ISI cut their price objective on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 7th. Rothschild & Co Redburn boosted their price objective on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, Royal Bank Of Canada set a $625.00 price objective on Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday. Eighteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $604.50.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.